Doximity, Inc. $DOCS Shares Sold by Lmcg Investments LLC

Lmcg Investments LLC decreased its holdings in shares of Doximity, Inc. (NASDAQ:DOCS) by 5.3% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 112,174 shares of the company’s stock after selling 6,223 shares during the quarter. Lmcg Investments LLC’s holdings in Doximity were worth $6,881,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. Ballentine Partners LLC acquired a new stake in shares of Doximity during the first quarter worth $201,000. Wealth Enhancement Advisory Services LLC boosted its holdings in shares of Doximity by 196.6% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 13,570 shares of the company’s stock worth $787,000 after purchasing an additional 8,995 shares during the last quarter. Bank of Nova Scotia acquired a new stake in shares of Doximity during the first quarter worth $651,000. New York State Teachers Retirement System boosted its holdings in shares of Doximity by 10.9% during the first quarter. New York State Teachers Retirement System now owns 113,145 shares of the company’s stock worth $6,566,000 after purchasing an additional 11,078 shares during the last quarter. Finally, Jump Financial LLC acquired a new stake in shares of Doximity during the first quarter worth $3,125,000. Institutional investors and hedge funds own 87.19% of the company’s stock.

Doximity Price Performance

Shares of DOCS opened at $65.70 on Friday. The stock’s 50-day moving average is $68.46 and its two-hundred day moving average is $60.96. The stock has a market cap of $12.31 billion, a PE ratio of 65.70, a P/E/G ratio of 4.10 and a beta of 1.38. Doximity, Inc. has a 12 month low of $40.87 and a 12 month high of $85.21.

Doximity (NASDAQ:DOCS) last issued its quarterly earnings data on Thursday, August 7th. The company reported $0.36 EPS for the quarter, topping analysts’ consensus estimates of $0.31 by $0.05. Doximity had a return on equity of 21.75% and a net margin of 36.60%.The business’s revenue was up 15.2% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.28 EPS. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. On average, research analysts anticipate that Doximity, Inc. will post 0.99 earnings per share for the current year.

Analyst Upgrades and Downgrades

DOCS has been the topic of a number of research analyst reports. The Goldman Sachs Group set a $64.00 target price on Doximity and gave the company a “sell” rating in a report on Wednesday, October 1st. Canaccord Genuity Group raised their price objective on Doximity from $59.00 to $67.00 and gave the stock a “hold” rating in a report on Thursday, September 18th. Raymond James Financial set a $75.00 price objective on Doximity in a report on Wednesday, September 10th. Wells Fargo & Company raised their price objective on Doximity from $55.00 to $62.00 and gave the stock an “equal weight” rating in a report on Monday, August 4th. Finally, JPMorgan Chase & Co. restated an “underweight” rating and issued a $62.00 price objective on shares of Doximity in a report on Friday. One equities research analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating, nine have issued a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $69.37.

Insider Buying and Selling

In related news, Director Regina M. Benjamin sold 5,000 shares of the business’s stock in a transaction dated Friday, September 12th. The stock was sold at an average price of $70.50, for a total value of $352,500.00. Following the transaction, the director owned 19,839 shares in the company, valued at approximately $1,398,649.50. The trade was a 20.13% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Timothy S. Cabral sold 20,000 shares of the business’s stock in a transaction dated Wednesday, September 24th. The shares were sold at an average price of $75.00, for a total value of $1,500,000.00. Following the completion of the sale, the director directly owned 3,221 shares of the company’s stock, valued at approximately $241,575. This represents a 86.13% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 32,000 shares of company stock worth $2,281,680. 31.30% of the stock is currently owned by corporate insiders.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.